Next 2-6 November the first ECMED Workshop will take place. ECMED is the acronym for “The Extracellular Matrix in Epileptogenesis” a consortium formed by 11 organizations from all over Europe with a joint objective: to design, validate and bring into practice new innovative therapeutic strategies against epilepsy. The first workshop, entitled “Understanding epilepsy and Practical workshop 1” will be held in Magdeburg, Germany. Delegates from the consortium members will gather together in order to delve into epilepsy. Besides, all early-stage researchers (ESRs) will deliver a short speech. In the case of Iproteos, Sandra Bertran will be the responsible to talk about peptidomimetics and her work in the search of novel agents to prevent epileptogenesis. Consortium’s projects are co-funded by the European Union’s Horizon 2020 research and innovation programme under a Marie Sklodowska-Curie grant (No. 645881).